The future was looking unbelievably bright for Forbes 30-under-30 healthcare golden boy Gabriel Otte, CEO of liquid biopsy startup Freenome, the recipient of $65M in seed funding from Silicon Valley venture capital firm Andreessen Horowitz, also known as a16z. A Cornell graduate who w...